Nature of nontransferrin-bound iron

European Journal of Clinical Investigation

Volumn 32, Issue SUPPL. 1, 2002, Pages 50-54

  Hider, R C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Iron; Nontransferrin bound iron

Indexed keywords

ALBUMIN; APOTRANSFERRIN; ASCORBIC ACID; CITRIC ACID; DNA; EDETIC ACID; FERRITIN; HEMOGLOBIN; IRON; IRON BINDING PROTEIN; IRON COMPLEX; NITRILOTRIACETIC ACID; OLIGOMER; OXYGEN; SCAVENGER; TRANSFERRIN; SERUM ALBUMIN;

COLORIMETRY; CROSS LINKING; DNA DAMAGE; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; METHODOLOGY; OLIGOMERIZATION; PH; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; REVIEW; TISSUE DISTRIBUTION; BLOOD; CHEMISTRY; DIMERIZATION; METABOLISM;

DIMERIZATION; HUMANS; IRON; SERUM ALBUMIN; TRANSFERRIN;

EID: 17944388628     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.0320s1050.x     Document Type: Review

References (52)

1. Hershko C. A study of the chelating agent diethylenetriamine pentaacetic acid using selective radio iron probes of reticuloendothelial and parenchymal iron stores. J Lab Clin Med 1975;85:913-21.
2. Hershko C, Rachmilewitz EA. Non-transferrin plasma iron in patients with transfusional iron overload. In: Crichton RR, editor. Proteins of Iron Storage and Transport in Biochemistry and Medicine. Amsterdam: North Holland Publishers; 1975, pp. 427-33.
3. Hershko C, Graham G, Bates GW, Rachmilewitz EA. Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol 1978;40:255-63.
4. Graham G, Bates GW, Rachmilewitz EA, Hershko C. Non-specific serum iron in thalassaemia: quantitation and chemical reactivity. Am J Hematol 1979;6:207-17.
5. Gutteridge JMC, Rowley DA, Griffiths E, Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci 1995;68:463-7.
6. Anuwatanakulchai M, Pootrakul P, Thuvasethakul P, Wasi P. Non-transferrin plasma iron in beta-thalassaemia/hbE and haemoglobin H diseases. Scand J Haematol 1984;32:153-8.
7. Wagstaff M, Peters SW, Jones BM, Jacobs A. Free iron and iron toxicity in iron overload. Br J Haematol 1985;61:566-7.
8. Wang WC, Ahmed N, Hanna M. Non-transferrin-bound iron in long-term transfusion in children with congenital anemia. J Pediatrics 1986;108:552-7.
9. Hershko C, Peto TEA. Non-transferrin plasma iron. Br J Haematol 1987;66:149-51.
10. Batey RG, Lai Chung Fong P, Shamir S, Sherlocks A. Non-transferrin-bound serum iron in idiopathic haemochromatosis. Dig Dis Sci 1980;25:340-6.
11. Aruoma OI, Bomford A, Polson RJ, Halliwell B. Non-transferrin-bound iron in plasma from haemochromatosis patients: Effects of phlebotomy therapy. Blood 1988;72:1416-9.
12. Gosriwatana I, Loréal O, Lu S, Brissot P, Porter J, Hider RC. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem 1999;273:212-20.
13. Loréal O, Gosriwatana I, Guyader D, Porter J, Brissot P, Hider RC. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol 2000;32:727-33.
14. De Valk B, Addicks MA, Gosriwatana I, Lu S, Hider RC, Marx JJM. Non-transfenin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 2000;30:248-51.
15. Halliwell B, Aruoma OI, Mufti G, Bomford A. Bleomycin-detectable iron in serum from leukaemic patients before and after chemjournalapy. Therapeutic implications for treatment with oxidant-generating drugs. FEBS Lett 1988;241:202-4.
16. Carmine TC, Evans P, Bruchelt G, Evans R, Handretinger R, Niethammer D, et al. Presence of iron catalytic for free radical reactions in patients undergoing chemjournalapy: implications for therapeutic management Cancer Lett 1995;94:219-26.
17. Dürken M, Nielsen P, Knobel S, Finckh B, Herrnring C, Dresow B, et al. Non-transferrin-bound iron in serum of patients receiving bone marrow transplants. Free Rad Biol Med 1997;22:1159-63.
18. Bradley SJ, Gosriwatana I, Srichairatanakool S, Hider RC, Porter JB. Non-transferrin-bound iron induced by myeloablative chemjournalapy. Br J Haematol 1997;99:337-43.
19. Baker E, Morgan EH. Iron transport. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, editors. Iron Metabolism in Health and Disease. London: Saunders; 1994, pp. 63-96.
20. Wheby MS, Umpierre G. Effect of transferrin saturation on iron absorption in man. New Eng J Med 1964;271:1391-5.
21. Brissot P, Wright TL, Ma WL, Weisiger RA. Efficient clearance of non-transferrin-bound iron by rat liver. J Clin Invest 1985;76:1463-70.
22. Wright TL, Brissot Ma WL, Weisiger RA. Characterisation of non-transferrin-bound iron clearance by rat liver. J Biol Chem 1986;261:10909-14.
23. Link G, Pinson A, Hershko C. Heart cells in culture: a model of myocardial iron overload and chelation. J Lab Clin Med 1985;106:147-53.
24. Bullen JJ, Griffiths E. Iron and Infection: Molecular, Physiological and Clinical Aspects. Chichester: J Wiley and Sons; 1999.
25. Schneider W. Iron hydrolysis and the biochemistry of iron - the interplay of hydroxide and biogenic ligands. Chimia 1988;42:9-20.
26. Spiro TG, Saltman P. Polynuclear complexes of iron and their biological implications. Structure Bonding 1969;6:116-56.
27. Flynn CM. Hydrolysis of inorganic iron (III) salts. Chem Rev 1984;84:31-41.
28. Van derWoude JHA, De Bruyn PL. Iron hydroxide polymers. Colloids Surfaces 1983;8:79-92.
29. Lippard SJ. Oxo-bridged poly iron centres in biology and chemistry. Angew Chem Int Ed Engl 1988;27:344-61.
30. Hagen KS. Synthetic models for iron-oxygen aggregation and biomineralization. Angew Chem Int Ed Engl 1992;31:1010-2.
31. 19 oxo-bridged iron clusters: The stabilization of high ground state spins by cluster aggregates. J Am Chem Soc 1995;117:2491-502.
32. Bino A, Shweky I, Cohen S, Bauminger ER, Lippard SJ. A novel nonairon (III) citrate complex: a 'ferric triple-decker'. Inorg Chem 1998;37:5168-72.
33. Pierre JL, Gautier-Lunear I. Iron and citric acid: a fuzzy chemistry of ubiquitous biological relevance. Biometals 2000;13:91-6.
34. May PM, Linder PW, Williams DR. Computer stimulation of metal-ion equilibria in bio fluids: Models for the low-molecular-weight complex distribution of calcium (II), magnesium (II), manganese (II), iron (III), copper (II), zinc (II) and lead (II) ions in human blood plasma. J Chem Soc Dalton 1977;588-95.
35. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. Non-transferrin-bound iron in plasma or serum from patients with idiopathic haemochromatosis. J Biol Chem 1989;264:4417-22.
36. Faller B, Nick H. Kinetics and mechanism of iron (III) removal from citrate by desferrioxamine B and 3-hydroxy-1, 2-dimethyl-4 pyridone. J Am Chem Soc 1994;116:3860-5.
37. Bates GW, Billups C, Saltman P. The kinetics and mechanism of iron (III) exchange between chelators and transferrin. I. The complexes of citrate and nitrilotracetic acid. J Biol Chem 1967;242:2810-5.
38. Peters T. All About Albumin: Biochemistry, Genetics and Medical Applications. San Diego, CA: Academic Press; 1996.
39. He SM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature 1992;358:209-15.
40. Lovstad RA. Interaction of serum albumin with the iron (III)-citrate complex. Int J Biochem 1993;25:1015-7.
41. Loban A, Kime R, Powers H. Iron-binding antioxidant potential of plasma albumin. Clin Sci 1997;93:445-51.
42. Van der Heul C, van Eijk HG, Wiltink WF, Leijnse B. The binding of iron to transferrin and to journal serum components at different degrees of saturation with iron. Clin Chim Acta 1972;38:347-53.
43. Gutteridge JMC, Rowley DA, Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Biochem J 1981;199:263-5.
44. Gutteridge JMC, Rowley DA, Halliwell B. Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Biochem J 1982;206:605-9.
45. Evans PJ, Halliwell B. Measurement of iron and copper in biological systems: Bleomycin and copper-phenanthroline assays. Meth Enzymol 1994;233:82-92.
46. Sahlsted TL, Ebeling F, Von Bonsdorff L, Parkkinen J, Ruutu T. Non-transferrin-bound iron during allogenic stem cell transplantation. Br J Haematol 2001;113:836-8.
47. Singh S, Hider RC, Porter JB. A direct method for quantification of non-transferin-bound iron. Anal Biochem 1990;186:320-3.
48. Zhang D, Okada S, Kawabata T, Yasuda T. An improved simple colorimetric method for quantification of non-transferrin-bound iron in serum. Biochem Mol Biol Int 1995;35:635-41.
49. Collins KE, Collins CH, Bertran CA, Dolan J. Stainless steel surfaces in LC systems, Part 1-corrosion and erosion. LC GC Int 2000;13:464-70.
50. He QY, Mason AB, Woodworth RC. Spectrophotometric titration with cobalt (III) for the determination of accurate absorption coefficients of transferrins. Biochem J 1996;318:145-8.
51. Breuer W, Ronson A, Sloti IN, Abramov A, Hershko C, Cabantchik ZI. The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood 2000;95:2975-82.
52. Breuer W, Ermers MJJ, Pootrakul P, Abramov A, Hershko C, Cabantchik ZI. Desferrioxamine-chelatable iron, a component of serum non-transferrin iron, used for assessing chelation therapy. Blood 2001;97:192-8.